Here's What to Expect From Teleflex's Next Earnings Report

Pennsylvania-based Teleflex Incorporated (TFX) is a global medical technology company specializing in the design, development, manufacturing, and supply of single-use medical devices for critical care and surgical applications. With a market capitalization of $8.4 billion, the company excels in areas such as vascular access, interventional cardiology, anesthesia, and urology, catering to a diverse customer base. Teleflex is set to release its fiscal fourth-quarter earnings for 2024 on Thursday, Feb. 27, before the market opens.

Ahead of the event, analysts expect TFX to report a profit of $3.86 per share on a diluted basis, up 14.2% from $3.38 per share in the year-ago quarter. The company has surpassed Wall Street’s EPS estimates in each of its last four quarterly reports. Its EPS of $3.49 in the recent quarter surpassed the consensus estimate by 3.3%.